##common.pageHeaderLogo.altText##

Vol. 3 No. 6 (2023)

Rectal Hemorrhage Revealing Rectal Cancer After Anticoagulation in A Patient with Acute Coronary Syndrome

Clinical Medicine And Health Research Journal, Vol. 3 No. 6 (2023), 22 November 2023 , Page 682-684
https://doi.org/10.18535/cmhrj.v3i6.276

Abstract

Cardiovascular diseases and cancer are the leading causes of mortality worldwide. The concomitant presence of cancer and acute coronary syndrome is not uncommon, ranging from 1.9% to 4.2%. We report our experience in a patient suffering from an acute coronary syndrome treated by medical treatment where the use of anticoagulants caused rectal bleeding revealing rectal cancer.

How to Cite

ABDELBAKI, M. ., & KHELLAFI, N. . (2023). Rectal Hemorrhage Revealing Rectal Cancer After Anticoagulation in A Patient with Acute Coronary Syndrome. Clinical Medicine And Health Research Journal, 3(6), 682–684. https://doi.org/10.18535/cmhrj.v3i6.276

Download Citation

References

  • Bharadwaj A, Potts J, Mohamed MO, Parwani P, Swamy P, Lopez-Mattei JC, et al. Acute myocardial infarction treatments and outcomes in 6.5 million patients with a current or historical diagnosis of cancer in the USA. Eur Heart J 2020;41:2183–2193. https:// doi.org/10.1093/eurheartj/ehz851
  • Velders MA, Boden H, Hofma SH, Osanto S, van der Hoeven BL, Heestermans AACM, et al. Outcome after ST elevation myocardial infarction in patients with cancer treated with primary percutaneous coronary intervention. Am J Cardiol 2013;112:1867–1872. https://doi.org/10.1016/j.amjcard.2013.08.019
  • Lyon AR, López-Fernández T, Couch LS, Asteggiano R, Aznar MC, Bergler-Klein J, et al. 2022 ESC Guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology (ESTRO) and the International Cardio-Oncology Society (IC-OS): developed by the Task Force on cardio-oncology of the European Society of Cardiology (ESC). Eur Heart J 2022;43:4229–4361. https://doi.org/10.1093/ eurheartj/ehac244
  • Potts JE, Iliescu CA, Lopez Mattei JC, Martinez SC, Holmvang L, Ludman P, et al. Percutaneous coronary intervention in cancer patients: a report of the prevalence and outcomes in the United States. Eur Heart J 2019;40:1790–1800. https://doi.org/ 10.1093/eurheartj/ehy769
  • Pothineni NV, Shah NN, Rochlani Y, Saad M, Kovelamudi S, Marmagkiolis K, et al. Temporal trends and outcomes of acute myocardial infarction in patients with cancer. Ann Transl Med 2017;5:482. https://doi.org/10.21037/atm.2017.11.29
  • Weintraub WS, Mahoney EM, Lamy A, Culler S, Yuan Y, Caro J, et al.. Clopidogrel in Unstable Angina to Prevent Recurrent Events Trial Investigators. Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation. N Engl J Med. (2001) 345:494–502. 10.1056/NEJMoa010746 [PubMed] [CrossRef] [Google Scholar]
  • Wallentin L, Becker RC, Budaj A, Cannon CP, Emanuelsson H, Held C, et al.. PLATO Investigators. Ticagrelor versus clopidogrel in patients with acute coronary syndromes. N Engl J Med. (2009) 361:1045–57. 10.1056/NEJMoa0904327 [PubMed] [CrossRef] [Google Scholar]
  • Yihong Sun, Lin Feng, Xian Li, Zhe Wang, Runlin Gao, and Yangfeng Wu, In-hospital major bleeding in patients with acute coronary syndrome medically treated with dual anti-platelet therapy: Associated factors and impact on mortality. Front Cardiovasc Med. 2022; 9: 878270. Published online 2022 Oct 31. doi: 10.3389/fcvm.2022.878270
  • Valgimigli M, Bueno H, Byrne RA, Collet JP, Costa F, Jeppsson A, Juni P, Kastrati A, Kolh P, Mauri L, Montalescot G, Neumann FJ, Petricevic M, Roffi M, Steg PG, Windecker S, Zamorano JL, Levine GN, ESC Scientific Document Group, ESC Committee for Practice Guidelines (CPG), ESC National Cardiac Societies. 2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS: The Task Force for dual antiplatelet therapy in coronary artery disease of the European Society of Cardiology (ESC) and of the European Association for Cardio-Thoracic Surgery (EACTS). Eur Heart J 2018;39:213_260.]
  • 2020 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation, Authors/Task Force Members: Jean-Philippe Collet (Chairperson) (France), Holger Thiele (Chairperson) (Germany), Emanuele Barbato (Italy), Olivier Barthe´le´my (France), Johann Bauersachs (Germany), Deepak L. Bhatt (United States of America), Paul Dendale (Belgium), Maria Dorobantu (Romania),Thor Edvardsen (Norway), Thierry Folliguet (France), Chris P. Gale (United Kingdom), Martine Gilard (France), Alexander Jobs (Germany), Peter Ju¨ni (Canada), Ekaterini Lambrinou (Cyprus), Basil S. Lewis (Israel), Julinda Mehilli (Germany), Emanuele Meliga (Italy), Be´ la Merkely (Hungary), Christian Mueller (Switzerland),
  • Marco Roffi (Switzerland), Frans H. Rutten (Netherlands), Dirk Sibbing (Germany), George C.M. Siontis (Switzerland), European Heart Journal (2021) 42, 1289_1367].
  • David Fitchett, MD, The impact of bleeding in patients with acute coronary syndromes: How to optimize the benefits of treatment and minimize the risk. Can J Cardiol. 2007 Jun; 23(8): 663–671. doi: 10.1016/s0828-282x(07)70229-5
  • Moscucci M, Fox KA, Cannon CP, et al. Predictors of major bleeding in acute coronary syndromes: The Global Registry of Acute Coronary Events (GRACE) Eur Heart J. 2003;24:1815–23. [PubMed] [Google Scholar]
  • A. Cordero, R. López-Palop, P. Carrillo, et al. Prevalence and postdischarge incidence of malignancies in patients with acute coronary syndrome.Rev Esp Cardiol., 71 (2018), pp. 267-273
  • Gerard Oristrell, Cancer and Acute Coronary Syndrome. A Close but Complicated Relationship. Rev Esp Cardiol., 71 (oct 2018), pp. 879-880
  • L.F. Nhola, H.R. Villarraga. Rationale for cardio-oncology units.Rev Esp Cardiol., 70 (2017), pp. 583-589.
    • Article Viewed: 0 Total Download

    ##plugins.themes.ojsPlusA.frontend.article.downloadstatastics##

    Cover Image

    Information